Van der Heijden C A, Den Tonkelaar E M, Garbis-Berkvens J M, Van Esch G J
Toxicology. 1981;19(2):139-50. doi: 10.1016/0300-483x(81)90095-0.
The carcinogenicity of maleic hydrazide is discussed by several national and international organizations because of contradictory results of a number of carcinogenicity studies carried out in the past. Because maleic hydrazide is used in agriculture on edible crops, an oral carcinogenicity study with rats was carried out for 28 months at dietary levels of 0, 1.0 and 2.0% maleic hydrazide which contained less than 1.5 mg hydrazine/kg product as impurity. In this study as well as in an experiment with mice carried out with the same batch of maleic hydrazide at the International Agency for Research on Cancer (IARC) in Lyon, France, treatment did not affect tumor incidence and it was concluded that maleic hydrazide itself is not a carcinogen. Most likely the presence of relatively high levels of hydrazine as an impurity was responsible for the contradictory results in studies as reported previously. Furthermore the results of this study showed that 1.0 and 2.0% maleic hydrazide in the diet caused proteinuria and increased protein/creatinine ratio's in the urine in both sexes without detectable histopathological changes in kidney or urinary tract. From this study, based on the effects of kidney function the "no-toxic" effect level is considered to be lower than 1.0% maleic hydrazide in the diet of rats.
由于过去进行的一些致癌性研究结果相互矛盾,几个国家和国际组织对马来酰肼的致癌性进行了讨论。由于马来酰肼用于食用作物的农业生产中,因此以0%、1.0%和2.0%的马来酰肼膳食水平对大鼠进行了为期28个月的口服致癌性研究,该马来酰肼产品中肼作为杂质的含量低于1.5mg/kg。在这项研究以及在法国里昂国际癌症研究机构(IARC)用同一批马来酰肼对小鼠进行的实验中,处理并未影响肿瘤发生率,得出的结论是马来酰肼本身不是致癌物。很可能是相对高水平的肼作为杂质导致了先前报道的研究结果相互矛盾。此外,这项研究的结果表明,饮食中1.0%和2.0%的马来酰肼会导致两性出现蛋白尿,并使尿液中的蛋白质/肌酐比值升高,而肾脏或尿路未检测到组织病理学变化。基于这项研究中肾功能的影响,大鼠饮食中马来酰肼的“无毒性”效应水平被认为低于1.0%。